Neda Khosravi
Overview
Explore the profile of Neda Khosravi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
67
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khosravi N, Pishavar E, Baradaran B, Oroojalian F, Mokhtarzadeh A
J Control Release
. 2022 Jun;
348:706-722.
PMID: 35732250
Nanomedicine research has advanced dramatically in recent decades. Nonetheless, traditional nanomedicine faces significant obstacles such as the low concentration of the drug at target sites and accelerated removal of the...
2.
Baradaran A, Asadzadeh Z, Hemmat N, Baghbanzadeh A, Shadbad M, Khosravi N, et al.
Biomed Pharmacother
. 2022 Jan;
146:112588.
PMID: 35062062
Tumor-associated macrophages (TAMs) are among the abundant cell populations of the tumor microenvironment (TME), which have pivotal roles in tumor development, chemoresistance, immune evasion, and metastasis. Growing evidence indicates that...
3.
Safaee S, Fardi M, Hemmat N, Khosravi N, Derakhshani A, Silvestris N, et al.
Molecules
. 2021 Feb;
26(4).
PMID: 33572092
Background: Glioma is an aggressive type of brain tumor that originated from neuroglia cells, accounts for about 80% of all malignant brain tumors. Glioma aggressiveness has been associated with extreme...
4.
Khosravi N, Shahgoli V, Amini M, Safaei S, Mokhtarzadeh A, Mansoori B, et al.
Eur J Pharmacol
. 2021 Jan;
894:173871.
PMID: 33460610
Nanog is a major transcription factor related to cellular multipotency that plays important roles in the development of tumor cells, drug resistance, migration, and stemness; indicating its great potential as...
5.
Khosravi N, Mokhtarzadeh A, Baghbanzadeh A, Hajiasgharzadeh K, Shahgoli V, Hemmat N, et al.
Life Sci
. 2020 Jun;
256:118005.
PMID: 32593711
Cancer is the second cause of mortality in the world after cardiovascular disease. Various studies attribute the emergence of therapeutic resistance in tumors to the presence of cancer stem cells...
6.
Amirghofran Z, Shekofteh N, Ghafourian M, Khosravi N, Kalantar K, Malek-Hosseini S
Asian Pac J Cancer Prev
. 2019 Jul;
20(7):1979-1988.
PMID: 31350954
Background: Immunomodulatory materials from natural herbs and the characterization of their immune enhancement
effects may have tremendous potential as cancer treatment. The aim of the present study was to investigate...
7.
Ghafourian Boroujerdnia M, Khosravi N, Malek-Hosseini S, Amirghofran Z
Pharm Biol
. 2014 Jul;
52(11):1471-7.
PMID: 24988124
Context: Euphorbia is an important Euphorbiaceae genus that is traditionally being used for various infections, inflammation, and cancer. Objective: The present study investigated the possible in vitro immunomodulatory effect of...